Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

OBJECTIVE: To estimate the impact of using the Aptima messenger RNA (mRNA) high-risk human papilloma virus (HR-HPV) assay versus a DNA HR-HPV assay in a primary HPV cervical screening programme. DESIGN: One hypothetical cohort followed for 3 years through HPV primary cervical screening. SETTING: Eng...

Descripción completa

Detalles Bibliográficos
Autores principales: Weston, Georgie, Dombrowski, Caroline, Harvey, Michael J, Iftner, Thomas, Kyrgiou, Maria, Founta, Christina, Adams, Elisabeth J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064071/
https://www.ncbi.nlm.nih.gov/pubmed/32152154
http://dx.doi.org/10.1136/bmjopen-2019-031303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064071/
https://www.ncbi.nlm.nih.gov/pubmed/32152154
http://dx.doi.org/10.1136/bmjopen-2019-031303

Ejemplares similares